Neith Corporation (6236.TWO)
TWD 29.65
(0.0%)
TWD 29.65
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 17.43 Million TWD | -14.42% |
| 2022 | 20.37 Million TWD | 300.85% |
| 2021 | 5.08 Million TWD | -51.35% |
| 2020 | 10.44 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 15 Million TWD | -13.95% |
| 2024 Q2 | 13.71 Million TWD | -8.57% |
| 2023 Q3 | 16.84 Million TWD | -25.45% |
| 2023 FY | 17.43 Million TWD | -14.42% |
| 2023 Q1 | 25.03 Million TWD | 0.0% |
| 2023 Q2 | 22.6 Million TWD | -9.72% |
| 2023 Q4 | 17.43 Million TWD | 3.47% |
| 2022 Q4 | - TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 97.012% |
| Level Biotechnology Inc. | 273.2 Million TWD | 93.619% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 87.351% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 91.172% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 98.687% |
| GlycoNex Incorporation | 276.39 Million TWD | 93.693% |
| VBI | 21.25 Million TWD | 17.966% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 94.443% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 96.613% |
| Visgeneer Inc. | 185.6 Million TWD | 90.607% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 98.683% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 97.622% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 85.456% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 99.224% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -163.418% |
| Enimmune corporation | 173.46 Million TWD | 89.95% |
| TaiRx, Inc. | 60.62 Million TWD | 71.245% |
| CHO Pharma, Inc. | 110.83 Million TWD | 84.271% |
| EirGenix Inc. | 1.14 Billion TWD | 98.478% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 84.432% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 96.598% |
| Lin BioScience, Inc. | 167.73 Million TWD | 89.607% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 81.398% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | 72.343% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 86.023% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 89.176% |
| RBC Bioscience Corporation | 513.08 Million TWD | 96.602% |
| BiOptic Inc. | 170.56 Million TWD | 89.779% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | 58.648% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | 25.035% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | 34.983% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 98.211% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -149.257% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | 17.87% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 95.267% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -118.678% |
| NaviFUS Corp. | 53.4 Million TWD | 67.355% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 96.379% |
| Sinew Pharma Inc. | 39.71 Million TWD | 56.104% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | 69.963% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 95.217% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 92.344% |
| AP Biosciences Inc | 106.65 Million TWD | 83.654% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 99.506% |
| 3D Global Biotech Inc. | 30.68 Million TWD | 43.18% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 91.105% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 98.87% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 97.988% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -87.937% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | 68.765% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 92.517% |
| TCI GENE Inc. | 155.54 Million TWD | 88.793% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | 31.657% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | 62.246% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 94.693% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | 73.133% |
| PharmaEngine, Inc. | 91 Million TWD | 80.844% |
| Savior Lifetec Corporation | 457.95 Million TWD | 96.193% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 84.286% |
| OBI Pharma, Inc. | 650.44 Million TWD | 97.32% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 95.539% |
| Acepodia, Inc. | 384.47 Million TWD | 95.466% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | 79.623% |